Caricamento...

Peroxisome Proliferator-Activated Receptor γ Controls Ingestive Behavior, Agouti-Related Protein, and Neuropeptide Y mRNA in the Arcuate Hypothalamus

Peroxisome proliferator-activated receptor γ (PPARγ) is clinically targeted for type II diabetes treatment; however, rosiglitazone (ROSI), a PPARγ agonist, increases food intake and body/fat mass as side-effects. Mechanisms for these effects and the role of PPARγ in feeding are not understood. There...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Neurosci
Autori principali: Garretson, John T., Teubner, Brett J.W., Grove, Kevin L., Vazdarjanova, Almira, Ryu, Vitaly, Bartness, Timothy J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Society for Neuroscience 2015
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4363385/
https://ncbi.nlm.nih.gov/pubmed/25788674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.2129-14.2015
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !